3-((2E)-3(aryl)prop-2-enoyl)-2H-chromen-2-one 3 was synthesized from 4-hydroxy coumarin by refluxing 3-acetyl-4-hydroxy coumarin with aromatic aldehydes in chloroform in the presence of a catalytic amount of piperidine. 3 was converted to pyrazoles 4, 5 by treatment with hydrazine and phenylhydrazine in toluene, respectively. The structures of the new compounds were confirmed by elemental analysis, IR, and multinuclear/multidimensional NMR spectroscopy ( 1 H, 13 C-NMR, NOESY, HMBC) which allowed us to assign the complete network of proton and carbon atoms. All the compounds exhibited one quasireversible redox process. All the newly synthesized compounds were screened for their antibacterial and antioxidant activities. Antimicrobial studies revealed that 3-(5-(2,5-dimethylphenyl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-one 5c showed significant antibacterial activity against Escherichia coli and Pseudomonas Aeruginosa 27853. Furthermore, 3-(5-(aryl)-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-ones 4, 5 showed antioxidant activities of different extents with respect to individual compounds as well as to the antioxidant methods. The 3-(5-(phenyl)-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-ones 4a was found to be the most active antioxidant in the series and more active than trolox which makes the investigated complexes a new promising class of antibacterial compounds.
Introduction
Chalcones are important precursors of flavonoids and isoflavonoids [1] . A large number of chalcones have been prepared by Claisen-Schmidt condensation of aldehydes with methyl ketones under basic conditions [2] . These compounds have shown in vitro antimalarial activity against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum [3] . Recently authors have reported the synthesis of chalcones under acidic conditions using perchloric acid and acetic acid [4] . The activity of a variety of chalcones as potent tyrosinase inhibitors and antioxidants has been also reported which are, thus, used as new depigmentation agents [5] . Nitrogen heterocycles containing chalcone moiety have been reported as active compounds against herpes simplex virus-1 (HSV-1) and human immunodeficiency virus 1 (HIV-1) [6, 7] . This class of compounds also exhibits cytotoxic activity towards leukemia cell lines [8, 9] . Various other chalcones exhibit insecticidal, antichinoviral, and antipicorniviral properties [10] .
On the other hand, coumarins and structurally related compounds have been shown to inhibit replication of HIV and thus exhibit a therapeutic potential [11] . A large number of structurally novel coumarin derivatives have been reported to show substantial cytotoxic and anti-HIV activity both in vitro and in vivo [12, 13] . A variety of synthetic coumarins have unique action mechanisms referring to the different stages of HIV replication [14] . Thus, coumarins are important lead compounds for the development of antiviral and/or virucidal drugs against HIV [15] [16] [17] .
In view of the variety of pharmacological properties exhibited by chalcones, we were prompted to undertake the synthesis of new compounds of this class and to study their conversion to other heterocycles which may show different or better physiological activities. We report herein the synthesis of new chalcone derivatives and their conversion to pyrazoles using nitrogen bases. In this regard it is worth stressing that also pyrazoles have been reported to show anti-inflammatory [18, 19] , cytotoxic [20] , insecticidal [21] , herbicidal [22] , and fungicidal [23, 24] activity.
Chemistry
Due to the exceptional reactivity of the acetyl group in 3-acetylchromone as well as the versatile biological activities of coumarin derivatives, the chalcone 3 was synthesized from 4-hydroxycoumarin (1) under mild basic conditions.
Compound 2 was prepared by reaction of 4-hydroxycoumarine with POCl 3 in chloroform in the presence of acetic acid, The resulting compound 2 was then reacted with arylaldehydes to give the (E) the coumarinic chalcones 3, which precipitated out from the hot MeOH solution after mixing 2 with the corresponding ArCHO Scheme 1.
3-((2E)-3(aryl) prop-2-enoyl)-2H-chromen-2-one compounds 3a-3e were identified from analysis of their spectroscopic data. The infrared (IR) spectrum of compound 3d showed the coumarin carbonyl groups at 1768 cm -1 , in addition to a broad band for the C=C group at 1595 cm -1 . The 1 H NMR spectrum showed trans olefinic protons H a and H b as ortho-coupled doublets at 8.25 (J = 15.6 Hz) and 6.92 (J = 15.9 Hz), respectively. The remaining aromatic protons of the aromatic aldehydes and the four protons of the coumarin moiety appeared as a multiplet in the region δ 7.25 -8.08. 13 C-NMR spectra as well as by NOESY and HMBC 2D-NMR experiments to elucidate their structures and assign completely the structural network of both protons and carbons. The spectral data were in accordance with the proposed structures (see experimental section).
The IR spectrum of 4d showed broad band at 3207 cm -1 due to the presence of the NH group. A sharp and strong absorption band at 1668 cm -1 indicated a carbonyl group in the compound.
Since chromone carbonyl groups usually appear as sharp absorption bands in the region 1620 -1650 cm -1 [26] , the band at 1684 cm -1 was assigned to coumarin rather than the chromone carbonyl group.
In addition, the detection of a strong C=N stretching band at 1608 cm −1 evidenced the formation of the pyrazole ring. The 1 H NMR spectra of 4d displays a signal at δ 4.12 ppm ascribable to the CH 2 protons of the pyrazole ring. A characteristic singlet proton signal at δ 4.81 ppm was assigned to CH proton from the pyrazole fragment. In addition, the aromatic protons (both coumarinic and aromatic) are observed between δ 6.82 and δ 8.1ppm (see experimental).
Full assignment of the 1 H NMR spectra of 4d was deduced from the NOESY spectrum. An observed NOE cross peak between H-1' and aromatic protons confirms that these two units are located on the same side of the pyrazole ring.
The structure of 4d was finally elucidated through the analysis of the 1 H, 13 C HMBC spectrum, which correlates the protons at δ 4.78 ppm with C 5' (δ 55.05 ppm) and C 2' (δ 153.3 ppm). The aromatic protons correlate with C 5' (δ 55, 05 ppm). (Table 1) 
A mechanistic rationalization for this reaction is straightforward and is provided in Scheme 3.
The first reaction step consists of a nucleophilic attack of the final hydrazine nitrogen atom to the carbonyl function followed by the elimination of water. The intermediate which forms may easily rearrange to afford the corresponding pyrazoles 4, 5.
Results and Discussion

Electrochemistry
Electrochemical studies of 3-(5-aryl-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-one, 5, are of interest due to the electron-deficient nature of the pyrazole unit.
Hence, the electrochemical properties of compounds 5a-e, were determined by cyclic voltammetry in CH 3 CN (1 × 10 -3 M) solutions, using 0.1 M tetrabutylammonium bromide (C 4 H 12 BrN) as the supporting electrolyte. Both platinum and gold were used as working electrodes, Ag/AgCl (0.1 M) as the reference electrode, and platinum as the counter electrode. Under these electrochemical conditions, 5 shows a quasi reversible behavior for the first reduction process. This can be deduced from the fact that the cathodic-anodic peak separations (Epc -Epa) are ca. 100 mV. The ratio of the peak current intensity for the cathodic and anodic processes is about 0.5 -0.7.
As expected, the reduction peak potential of the 3-(5-aryl-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-one 5 are strongly influenced by the para substitutent on the phenylene ring. Compared to the unsubstituted compound 5, the presence of electron donor groups such as the methoxy group shifts the reduction peak potential of 5 to more negative values. The redox behavior of all the new pyrazoles are summarized in Figure 1 All the compounds exhibited one quasireversible redox processes. For example, compounds 5d showed one quasireversible reduction at -0.8 V and -1.15 V, respectively. We assume that the curve at lower reduction potential may be due to the more electron-deficient dications in the ring system, and the curve at higher reduction potential may be attributed to the redox behavior of the pyrazole unit.
Antibacterial and Antioxidant Studies
Free radical scavenging activity assay
The free radical scavenging activity of the new 3-(5-aryl-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-one 4, 5 was tested by utilizing DPPH scavenging [34] .
DPPH is a free radical and accepts one electron or one hydrogen radical to become a stable diamagnetic molecule [27] . The reduction capability of DPPH radical was determined by the decrease in absorbance induced by 3-(5-aryl-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-one 4, 5. Briefly, 1.5 ml ethanolic solution of the synthesized compounds (0.2 mM) was added to 1.5 ml (0.2 mM) solution of DPPH radical in ethanol (final concentration of DPPH and synthesized compounds was 0.1 mM). The mixture was shaken vigorously and allowed to stand for 30 min. After this, the absorbance at 534 nm was determined and the percentage of scavenging activity was calculated using the following formula: 
Scavenging activity = {[(Ab+ As) -Am]/Ab}×100%
Ab: absorbance of 0.1 mM ethanolic solution of DPPH at 534 nm, As: absorbance of 0.1 mM ethanolic solution of test compound at 534 nm, Am: absorbance of ethanolic mixture of the drug and DPPH at 534 nm.
Trolox was used as reference compound. All tests and analyses were done on triplicate and averaged on three samples. The results are given in Scheme 4.
Among the compounds from the 3-(5-aryl-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-one 4 series, 4b showed moderate antioxidant activity.
The activity exhibited by the compound 4e was the highest. In addition the experimental data show that compound 4a scavenges free radical better than Trolox.
According to the experimental results, we notice that increasing the concentration of pyrazole percentage of inhibition reaches 90% for a concentration about 1 µM for all the synthesized products. Thus, we can conclude that substituents on the aryl group do not influence significantly the anti-oxidant activity.
One parameter that has been introduced recently for the interpretation of the results from the DPPH method is the efficient concentration or EC 50 value (otherwise called the IC 50 value), which is defined as the concentration of substrate that causes 50% loss of the DPPH activity (color) and corresponds to the endpoint of the titration. In all cases, any residual (yellow) color from the reduced form or any non specific absorbance from the sample should be considered in defining the ''endpoint'' of the titration, i.e., the 50% point. Additionally, this IC 50 parameter has also the drawback that the higher the antioxidant activity, the lower is the value of EC 50 .
The EC 50 values exhibited by 3-(5-aryl-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-one 4, 5 are summarized in the following Table 2 .
From inspection of Table 2 , it is evident that pyrazoles 4,5 are more active than trolox. at 734 nm. In a final volume of 1 ml, the reaction mixture comprised 950 µl of ABTS ± solution and 50 µl of the pyrazoles 4, 5 at various concentrations. The reaction mixture was homogenized and its absorbance was recorded at 734 nm. Ethanol blanks were run in each assay, and all measurements were done after at least 6 min. Similarly, the reaction mixture of standard group was obtained by mixing 950 ll of ABTS + solution and 50 µl of TROLOX. As for the antiradical activity, ABTS sca-venging ability was expressed as EC 50 (<mu> g/ml). The inhibition percentage of ABTS radical was calculated using the following formula:
where A 0 is the absorbance of the control at 30 min, and A1 is the absorbance of the Sample at 30 min. All samples were analyzed in triplicate.
As shown for DPPH scavenging, these data indicate the higher capacity of 3-(5-aryl-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-one 4, 5 to quench ABTS + as compared to the synthetic antioxidant TROLOX.
The variation of the percentage of inhibition (PI) is almost constant starting from a value of the concentration equal to 1, 34 mM. In addition, the synthesized products 5 have an antioxidant activity better than Trolox. Indeed, the antioxydant capacity seems to be attenuated when the concentration increases in the medium. This can be explained by the existence of the peroxides sites which are susceptible for oxidizing when the concentration increases. We have just shown that the synthesized pyrazoles derivatives 4, 5 have a good antioxidant activity under weak concentration, but it proves to be necessary to determine the reaction time necessary to highlight the antioxidant effect to be able to use these derivatives in pharmay.
The EC 50 values exhibited by 3-(5-aryl-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-one 4, 5 are summarized in the following Table 3 .
The 3-(5-aryl-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-one 4, 5 were shown to be efficient antioxidants. They showed higher free radical scavenging activity than Trolox scavenging activities.
These compounds have a remarkable capacity oxidizing which explains their susceptibility to fix free radicals DPPH and ABTS + .
Antibacterial Activity
The antibacterial activity of 3-(5-aryl-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-one 4 was assessed by the agar disk diffusion assay [28] Table 4 below. 
-22 Gentamycin
The residual antibacterial activity of the compounds was tested by disc diffusion assay against the indicator strain in LB medium at 28˚C ATCC: American Type Culture Collection, USA; CIP: Collection de l'Institut Pasteur, Paris, France LM: Laboratoire de Microbiologie, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia Methicillin-resistant clinical isolates An examination of the data reveals that all the compounds showed antibacterial activity ranging from 25 to 100 μg ml -1 . The compounds 5a and 5e were highly active against all the five organisms employed. Compound 5c was highly active against E. coli. From the screened results, it is observed that the presence of methoxy/NO 2 group at the phenyl ring increases the antibacterial activity. The highest activity was found in compound 5b bearing a methoxy group at 4-position.
Conclusions
A new versatile synthetic route to 3-(5-aryl-4,5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H-chromene-2-one 4, 5 by the treatment of 4-hydroxycoumarine with different reagents is described. The method is easy, rapid and yielded the title compounds 4, 5 in good yields. The structures of the novel compounds were verified by, IR 1D/2D NMR spectroscopy. All the newly synthesized compounds were screened for their antibacterial and antioxidant activities. Among the screened samples, compounds 5a and 5b showed excellent antibacterial activity against E. coli. Compounds with 4-phenyl, 4-methoxyphenyl, 4-fluorophenyl and 4-nitrophenyl substituents in the pyrazole ring exhibited higher antioxidant activity than trolox while the pyrazole bearing a p-methoxy substituent in the phenyl ring exhibited enhanced antioxidant activity.
Experimental Section
General
All reactions were magnetically stirred. Commercially available reagents were used without further purification. All chemicals were supplied from Aldrich, Merck andFluka Co. Melting points were determined by open capillary method and were uncorrected.
All reactions were monitored by thin layer chromatography (TLC). Compounds were visualized with UV light at 254 and 365 nm. Melting points were measured on a WRX-1S instrument. Infrared (IR) spectra were recorded with a Perkin-Elmer spectrum one B spectrometer. 1 H and 13 C{ 1 H} NMR spectra were recorded on a Varian-Unity spectrometer at 300 MHz using tetramethylsilane (TMS) as an internal standard. Cyclic voltammetry (CV) was performed on a BAS 100 BW electrochemical workstation. All CV measurements were carried out using tetrabutylammonium bromide (C 4 H 12 BrN) as a supporting electrolyte, purging with nitrogen prior to conduct the experiment. Platinum wire (MF-2013) was used as a working electrode, Ag/AgCl as a reference electrode, and another platinum wire (MF-1032) as a counter electrode.
3-Acetyl-4-hydroxycoumarin
To a solution of 4-hydroxy-2H-chromen-2-one (3.0 g, 1.86mmol) in acetic acid (16 ml) phosphorus oxychloride (5.6 ml) was added. The mixture was heated at reflux for 30 min. After cooling to room temperature, the precipitate which separated out was collected by filtration and recrystallized from ethanol to give 3-acetyl-4-hydroxy-2Hchromen-2-one as white needles. Yield 2.7 g (90%); Mp = 135˚C. IR spectrum, ν cm -1 : 3185 (OH); 1705 (CO); 1700 (O-CO lactone). (phenyl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl) (5-(2,5-dimethylphenyl)-1-phenyl-4,5-dihydro-1H-p  yrazol-3-yl) 
3-(5-
